Gyre Therapeutics Ownership | Who Owns Gyre Therapeutics?
Gyre Therapeutics Ownership Summary
Gyre Therapeutics is owned by 1.59% institutional investors, 87.10% insiders, and 11.31% retail investors. Vanguard group is the largest institutional shareholder, holding 1.35% of GYRE shares.
GYRE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Gyre Therapeutics | 1.59% | 87.10% | 11.31% |
| Sector | Healthcare Stocks | 232.51% | 10.72% | -143.23% |
| Industry | Biotech Stocks | 384.56% | 10.58% | -295.14% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 1.20M | 1.35% | $8.48M |
| Blackrock funding, inc. /de | 720.29K | 0.81% | $5.09M |
| Geode capital management | 423.22K | 0.47% | $2.99M |
| State street | 182.75K | 0.21% | $1.36M |
| Sbi securities | 162.91K | 0.18% | $1.15M |
| Charles schwab investment management | 123.39K | 0.14% | $920.46K |
| Northern trust | 116.34K | 0.13% | $867.91K |
| Morgan stanley | 54.50K | 0.06% | $384.76K |
| Bank of new york mellon | 41.20K | 0.05% | $290.89K |
| State of wisconsin investment board | 39.00K | 0.04% | $290.94K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sbi securities | 162.91K | 0.03% | $1.15M |
| State of wisconsin investment board | 39.00K | 0.00% | $290.94K |
| Activest wealth management | 533.00 | 0.00% | $3.76K |
| Tower research capital llc (trc) | 2.69K | 0.00% | $20.10K |
| Strs ohio | 21.10K | 0.00% | $148.97K |
| State of alaska, department of revenue | 5.22K | 0.00% | $36.00K |
| Geode capital management | 423.22K | 0.00% | $2.99M |
| Northern trust | 116.34K | 0.00% | $867.91K |
| Rhumbline advisers | 13.43K | 0.00% | $100.20K |
| Mirae asset global etfs | 4.20K | 0.00% | $31.35K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 720.29K | 0.00% | 60.89K |
| Vanguard group | 1.20M | 0.00% | 51.03K |
| Geode capital management | 423.22K | 0.00% | 48.60K |
| Morgan stanley | 54.50K | - | 45.52K |
| Bank of new york mellon | 41.20K | 0.00% | 16.80K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Northern trust | 116.34K | 0.00% | -26.99K |
| Nuveen | - | - | -17.59K |
| Advantage alpha capital partners lp | - | - | -13.66K |
| Ubs group | 9.58K | - | -13.38K |
| Verition fund management | - | - | -13.35K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Dimensional fund advisors lp | 10.90K | - | 10.90K | $76.97K |
| Russell investments group | 1.12K | - | 1.12K | $8.38K |
| Optiver b.v. | 222.00 | - | 222.00 | $1.66K |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -6.00 |
| Us bancorp \de\ | -17.00 |
| Rise advisors | -54.00 |
| Srs capital advisors | -57.00 |
| Federation des caisses desjardins du quebec | -75.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | -78.26% | 1,417,139 | -54.22% | 1 | 13.18% | 3 | -87.50% | 3 | -78.57% |
| Sep 30, 2025 | 15 | -65.12% | 1,514,519 | -54.84% | 1 | 12.00% | 6 | -80.65% | 5 | -28.57% |
| Jun 30, 2025 | 46 | 4.55% | 3,409,780 | 30.67% | 3 | 41.97% | 34 | 47.83% | 7 | -50.00% |
| Mar 31, 2025 | 44 | 15.79% | 2,609,380 | 57.10% | 3 | 80.28% | 23 | 15.00% | 14 | 55.56% |
| Dec 31, 2024 | 39 | 11.43% | 1,787,607 | 11.02% | 2 | 59.05% | 21 | -4.55% | 9 | 50.00% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 28, 2025 | Ma Songjiang | President | Sell | $5.62K |
| May 27, 2025 | Ma Songjiang | President | Sell | $20.56K |
| May 23, 2025 | Ma Songjiang | President | Sell | $1.86K |
| May 22, 2025 | Ma Songjiang | President | Sell | $21.94K |
| May 20, 2025 | Ma Songjiang | President | Sell | $22.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | 12 |
| 2025 Q1 | - | 59 |
| 2024 Q4 | - | 14 |
GYRE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools